Concepedia

Howard Mayer

HM

Statistics

Publications

14

Citations

2.7K

H-Index

14

Active since

1998

Affiliations

Pfizer (United States)(Current)

Pfizer (United Kingdom)

Chelsea and Westminster Hospital

Centre Hospitalier Universitaire de Saint-Pierre

University of Alabama at Birmingham

Howard Mayer is an author at Pfizer (United States) specializing in antiretroviral therapy, antiviral therapy, and pharmacotherapy.

Publications per year

1998–2012

14

Publications

14

Maraviroc for Previously Treated Patients with R5 HIV-1 Infection

Roy M. Gulick, Jacob Lalezari, James Goodrich et al. · New England Journal of Medicine · 2008 · 741 citations · Full text

, , +17

Subgroup Analyses of Maraviroc in Previously Treated R5 HIV-1 Infection

Gerd Fätkenheuer, Mark Nelson, Adriano Lazzarin et al. · New England Journal of Medicine · 2008 · 361 citations · Full text

, , +17

Pharmacodynamics of Fluoroquinolones against <i>Streptococcus pneumoniae</i> in Patients with Community-Acquired Respiratory Tract Infections

Paul G. Ambrose, Dennis M. Grasela, Thaddeus H. Grasela et al. · Antimicrobial Agents and Chemotherapy · 2001 · 298 citations · Full text

, , +16

Molecular and Clinical Epidemiology of CXCR4‐Using HIV‐1 in a Large Population of Antiretroviral‐Naive Individuals

Zabrina L. Brumme, James Goodrich, Howard Mayer et al. · The Journal of Infectious Diseases · 2005 · 270 citations · Full text

, , +9

Maraviroc versus Efavirenz, Both in Combination with Zidovudine‐Lamivudine, for the Treatment of Antiretroviral‐Naive Subjects with CCR5‐Tropic HIV‐1 Infection

David A. Cooper, Jayvant Heera, James Goodrich et al. · The Journal of Infectious Diseases · 2010 · 265 citations

, , +15

1–5 of 14